A Stony Brook's Breast Cancer Research Retreat - January 12, 2013
Welcome | Kenneth Kaushansky, MD, MACP Senior Vice President, Health Sciences Dean, Stony Brook University School of Medicine |
Introduction | Yusuf Hannun, MD Director, Stony Brook Cancer Center Vice Dean, Cancer Medicine |
Session I | BREAST CANCER BIOLOSY AND SIGNALING (Chair: Natalia Marchenko, PhD) Ute Moll, MD, MS: Stabilized mutp53 as Cancer-Specific Drug Target: the HDAC6-Hsp90 Chaperone Axis |
Session II | BREAST CANCER PATHOLOGY AND METASTASES (Chair: Barbara Nemesure, PhD) Kenneth Shroyer, MD, PhD: Discovery and Validation of a Stage Specific Biomarker for Cancer Survival. Pathology Resources and Approach |
Sesssion III | BREAST CANCER CLINICAL TRIALS/BIOMARKERS AND IMAGING (Chair: Janice Lu, MD, PhD) Dr. Janice Lu: NSABP Neoadjuvant Targeted Anti-Her2 Therapy and Correlated Breast Cancer Biomarkers
BREAST CANCER CLINICAL PROGRAM |
Sesssion IV | EARLY STAGE TRANSLATIONAL RESEARCH - BENCH TO BEDSIDE (Chair: Wei Zhao, PhD) Jian Cao, MD: Development of Novel Inhibitory Peptides for Targeting Disseminated Cancer Cells |
Sesssion V | BREAST CANCER THERAPEUTICS/GENOMICS (Chair: Michael Hayman, PhD) Lina Obeid, MD: Role for a Sphingolipid Mediated Pathway in Cell Invasion |
Sesssion VI | LATER STAGE TRANSLATION RESEARCH - BEDSIDE TO CLINICAL CARE IMPROVEMENTS (Chair: Christine Rizk, MD) Dr. Christine Rizk: An Examination of the Link Between Smoking and Breast Cancer |
Closing Remarks | (Drs. Janice Lu and Christine Rizk) |
Posters | (Shared Resources/Cores and Individual Labs) |